Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05202171
Other study ID # 2022/01/8
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 2022
Est. completion date June 2023

Study information

Verified date January 2022
Source Ankara Yildirim Beyazit University
Contact Seyda Toprak Celenay
Phone +90312 906 1000
Email sydtoprak@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of our study is to investigate the effects of cervical stabilization exercise training applied with telerehabilitation in individuals with migraine.


Description:

Cervical muscles are adversely affected in individuals with migraine. It is important to investigate the effects of cervical muscle training in these individuals. Telerehabilitation applications have been used frequently in many patients in recent years. It is necessary to examine the effects of cervical stabilization exercises applied with telerehabilitation in individuals with migraine.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date June 2023
Est. primary completion date February 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Being between the ages of 18-55, - To be diagnosed with migraine by a neurologist according to International Headache Society criteria, - Having at least 3 migraine attacks per month, - Volunteering to participate in the study, - Having the opportunity to access devices such as computers, phones and tablets with internet connection, - Not having any problems that prevent cooperation and understanding Exclusion Criteria: - Having other accompanying headache types, - Being pregnant, - Being in the breastfeeding period, - Having a history of trauma, fracture or surgery in the craniocervical region, - Presence of concomitant neurological and/or inflammatory rheumatic disease - Presence of serious psychiatric problems, - History of malignancy, - Changes in medical treatment during the study period, - Receiving physiotherapy for the cervical region in the last 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cervical Stabilization Exercise
Exercise group will be performed cervical stabilization exercise training applied with telerehabilitation and standard treatment ( preventive/symptomatic oral drug therapy routinely in the clinic and suggestions for triggering factors in migraine) for 8 weeks
Standard treatment
standard treatment will include preventive/symptomatic oral drug therapy routinely in the clinic and suggestions for triggering factors in migraine for 8 weeks

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ankara Yildirim Beyazit University

Outcome

Type Measure Description Time frame Safety issue
Primary The characteristic of the migraine The characteristic of the migraine will be evaluated with the "Headache Diary". change from baseline at 8 weeks
Secondary Cervical range of motion Cervical range of motion was evaluated using the goniometer change from baseline at 8 weeks
Secondary Upper cervical region movements Upper cervical region movements will be evaluated with a Cervical Range of Motion device change from baseline at 8 weeks
Secondary Performance of the deep neck flexor muscles Performance of the deep neck flexor muscles will be evaluated with a Stabilizer Pressure Biofeedback Unit change from baseline at 8 weeks
Secondary Cranio-vertebral angle The cranio-vertebral angle will be measured with a goniometer change from baseline at 8 weeks
Secondary Disability Status The Turkish version of Migraine Disability Assessment Scale will be used to determine the disability status in daily activities of individuals due to migraine change from baseline at 8 weeks
Secondary Sleep quality Sleep quality will be evaluated with the Turkish version of Jenkins Sleep Scale change from baseline at 8 weeks
Secondary Life quality Life quality will be evaluated with the Turkish version of Headache Impact Test change from baseline at 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT05525611 - Cabergoline as a Preventive Treatment for Chronic Migraine N/A
Completed NCT06192173 - Patent Foramen Ovale Closure in Migraine
Recruiting NCT03832998 - Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Phase 3
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Not yet recruiting NCT06428838 - Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context Phase 3
Completed NCT06304675 - Manageable Environmental Factors in Migraine
Completed NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study Phase 4
Recruiting NCT05517200 - Pilot Study for a Machine Learning Test for Migraine
Completed NCT04179474 - Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine Phase 1
Recruiting NCT04603976 - Registry for Migraine - Clinical Core Phase 4
Completed NCT03597529 - CHOCOlate MeLatonin for AdolescenT MigrainE Phase 2
Completed NCT04197349 - Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman Phase 1
Recruiting NCT05891808 - miR-155 Expression in Episodic and Chronic Migraine
Active, not recruiting NCT05064371 - Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan Phase 3
Suspended NCT04069572 - Vibratory Stimulation for the Treatment of Chronic Pain N/A
Not yet recruiting NCT04859374 - Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach N/A
Not yet recruiting NCT03083860 - Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions. N/A
Completed NCT02905227 - A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder Phase 1
Enrolling by invitation NCT02532023 - The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients Phase 4
Completed NCT02108678 - One-Day Intervention for Depression and Impairment in Migraine Patients N/A